Suppr超能文献

对人结肠肿瘤细胞的抗体依赖性细胞毒性。II. 相关抗原的分析。

Antibody-dependent cellular cytotoxicity to human colon-tumour cells. II. Analysis of the antigens involved.

作者信息

Shoham J, Cohen M

出版信息

Br J Cancer. 1979 Aug;40(2):244-52. doi: 10.1038/bjc.1979.172.

Abstract

The relationship between carcinoembryonic antigen (CEA) and A antigenic determinants on the cell surface of colon-tumour cells was studied by the ADCC assay. Antiserum prepared in 2 rabbits to an undecapeptide analogous to the amino terminal of CEA(1-11) was found by us either to participate in (Rabbit 2) or specifically inhibit (Rabbit 1) ADCC. The binding spectra of these two antisera and of antiserum to the whole CEA molecule were similar. All of them react with A and non-A colon-tumour cells as well as red blood cells of Type A (RBC-A) and their activity was completely absorbed on RBC-A but not on B or O. O-type, ADCC-reactive human sera always react with A-type colon-tumour cells and RBC-A, and some of them with non-A colon-tumour cells also. The degree of inhibition of their reactivity by anti-CEA(1-11) R1 varied between sera, from none to almost a complete inhibition, and is not related to whether the serum is of cancer or non-cancer origin. Non-reactive O-type sera contain anti-A activity demonstrable by haemagglutination and immunofluorescence. However, they cannot participate in ADCC reaction nor inhibit it. The sera, which contain lymphocyte-dependent antibody to A-type colon-tumour cells, lysed RBC-A, without the addition of lymphocytes or complement, in an immunologically specific way. It is concluded that the reactivity seen in our ADCC system is related to a determinant common to A and CEA (and maybe to other normal cross-reacting antigens) which most probably resides in the amino terminal part of these molecules. This determinant elicits the production of lymphocyte-dependent antibodies in about 50% of people with blood group O. Thus, the amino terminal part of CEA is not a tumour-specific part of the CEA molecule. No specific anti-tumour activity was found in patients' serum by this method, and claims for its demonstration by other methods may well be related to the non-specific activity observed here.

摘要

采用抗体依赖的细胞介导的细胞毒性(ADCC)试验研究了癌胚抗原(CEA)与结肠肿瘤细胞表面A抗原决定簇之间的关系。我们发现,用2只兔子制备的针对与CEA(1-11)氨基末端类似的十一肽的抗血清,其中一只兔子的抗血清(兔子2)参与了ADCC反应,而另一只兔子的抗血清(兔子1)则特异性抑制了ADCC反应。这两种抗血清以及针对整个CEA分子的抗血清的结合谱相似。它们都能与A和非A结肠肿瘤细胞以及A型红细胞(RBC-A)发生反应,并且它们的活性在RBC-A上被完全吸收,而在B型或O型红细胞上则不会。O型、具有ADCC反应性的人血清总是与A型结肠肿瘤细胞和RBC-A发生反应,其中一些血清也与非A结肠肿瘤细胞发生反应。抗CEA(1-11)R1对其反应性的抑制程度在不同血清之间有所不同,从无抑制到几乎完全抑制,并且与血清是癌症来源还是非癌症来源无关。无反应性的O型血清含有可通过血凝和免疫荧光检测到的抗A活性。然而,它们既不能参与ADCC反应也不能抑制ADCC反应。含有针对A型结肠肿瘤细胞的淋巴细胞依赖性抗体的血清,在不添加淋巴细胞或补体的情况下,以免疫特异性方式裂解了RBC-A。由此得出结论,我们的ADCC系统中观察到的反应性与A和CEA共有的一个决定簇(可能还与其他正常交叉反应抗原)有关,这个决定簇很可能位于这些分子的氨基末端部分。这个决定簇在大约50%的O型血人群中引发淋巴细胞依赖性抗体的产生。因此,CEA的氨基末端部分不是CEA分子的肿瘤特异性部分。通过这种方法在患者血清中未发现特异性抗肿瘤活性,而其他方法声称证明了其存在,很可能与这里观察到的非特异性活性有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63b1/2010009/bc4a0102a18e/brjcancer00142-0068-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验